BioMarin Pharmaceutical Inc. (BMRN) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 10.63B USD. 52-week range 49.26 to 70.98 USD. Trailing P/E 148.4. Data as of 2026-10-09.
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic ...